investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

James C Paulson

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

James C Paulson

Scripps Research Institute

San Diego, United States

Related projects

Ronald Hoffman

Myeloproliferative Disorders (MPD) Research Consortium

Leukaemia

Hematology and hematologic malignancies

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies

Javier Adachi

Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Scott H Kaufmann

Anticancer Drug-Induced BH3-only Protein.Bak Interactions

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Eduardo Sotomayor

Research in Transformed and Aggressive B-cell lymphomas; Personalized Medicine Initiatives

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Sophia S Wang

Autoimmune Conditions, Genetic Variations, and Lymphoma Etiology

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Roland B Walter

Prediction of Treatment-Related Mortality and Therapeutic Resistance in AML

Leukaemia

Hematology and hematologic malignancies

Sign Up For Updates

Stay up to date with what's going on with The GO Map.